KPC Pharmaceuticals Plans to Sell Up to 2,443,022 Shares of Leed Biotech

证券时报··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

KPC Pharmaceuticals announced that, in order to further strengthen its core business and optimize its asset structure, the company plans to sell up to 2,443,022 shares of Nanjing Leed Biotech Co., Ltd. through methods such as centralized bidding and block trades at an opportune time.

Impact on assets 1

Others▼
KPC Pharmaceuticals Inc
600422
▼ NegativeCapitalrelevance

KPC Pharmaceuticals plans to sell shares of Leed Biotech, which may signal a need to raise cash or divest assets, potentially reducing its investment value.